MANUFACTURERS LIFE INSURANCE COMPANY, THE - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 49 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$117,000
-23.5%
35,790
+4.5%
0.00%
Q3 2021$153,000
-23.1%
34,245
-6.3%
0.00%
Q2 2021$199,000
-6.1%
36,533
+28.6%
0.00%
Q1 2021$212,000
-25.1%
28,405
+8.9%
0.00%
Q4 2020$283,000
+26.9%
26,079
+3.2%
0.00%
Q3 2020$223,000
-16.2%
25,2620.0%0.00%
Q2 2020$266,000
+94.2%
25,262
+9.1%
0.00%
Q1 2020$137,000
-8.1%
23,165
+7.6%
0.00%
Q4 2019$149,000
-36.9%
21,535
-4.8%
0.00%
Q3 2019$236,000
+7.8%
22,623
-4.4%
0.00%
Q2 2019$219,000
+135.5%
23,663
+132.2%
0.00%
Q1 2019$93,000
-24.4%
10,190
-1.7%
0.00%
Q3 2018$123,000
-40.9%
10,362
-49.3%
0.00%
Q2 2018$208,000
+23.8%
20,432
+58.1%
0.00%
Q1 2018$168,000
+425.0%
12,922
+299.9%
0.00%
Q4 2017$32,000
-68.3%
3,231
-52.9%
0.00%
Q3 2017$101,000
-40.6%
6,867
-35.0%
0.00%
Q2 2017$170,000
+16900.0%
10,559
+11253.8%
0.00%
Q1 2017$1,0000.0%930.0%0.00%
Q4 2016$1,000930.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,726,603$15,228,00010.06%
Flagship Pioneering Inc. 3,204,437$29,673,0001.28%
Redmile Group, LLC 3,620,376$33,525,0000.95%
ARK Investment Management 3,791,756$35,112,0000.88%
Nikko Asset Management Americas, Inc. 2,987,763$27,667,0000.54%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,268,946$11,750,0000.42%
683 Capital Management, LLC 429,775$3,980,0000.36%
EcoR1 Capital, LLC 248,480$2,301,0000.23%
ALGERT GLOBAL LLC 17,920$166,0000.06%
Baker Brothers Advisors 974,835$9,027,0000.06%
View complete list of SYROS PHARMACEUTICALS INC shareholders